Cutaneous lichen planus
Clinical trials for Cutaneous lichen planus explained in plain language.
Never miss a new study
Get alerted when new Cutaneous lichen planus trials appear
Sign up with your email to follow new studies for Cutaneous lichen planus, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug clear the skin in lichen planus?
Disease control Recruiting nowThis trial is testing an investigational drug called GIA632 in people with moderate-to-severe cutaneous lichen planus, a skin condition that causes itchy, purple bumps. The study aims to see if GIA632 can clear or nearly clear the skin rash and reduce itching compared to a placeb…
Matched conditions: CUTANEOUS LICHEN PLANUS
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New skin disease drug enters first human trials
Disease control Recruiting nowThis study tests a new drug called BG-A3004 for the first time in humans. It aims to check the drug's safety and how the body processes it in healthy volunteers and people with immune-related skin diseases. The study is split into two parts: single dose in healthy people and mult…
Matched conditions: CUTANEOUS LICHEN PLANUS
Phase 1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC